Improving outcomes of acute myocarditis in children

Expert Review of Cardiovascular Therapy

Volumn 14, Issue 1, 2016, Pages 117-125

  Di Filippo, Sylvie ^a  

^a University Medical Center of Lyon   (France)

Author keywords

Acute myocarditis; Diagnosis; Outcome; Prognosis; Treatment

Indexed keywords

ALDOSTERONE ANTAGONIST; ANTIVIRUS AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT;

ACUTE DISEASE; ACUTE VIRAL MYOCARDITIS; ANTIVIRAL THERAPY; CHILDHOOD DISEASE; EXTRACORPOREAL OXYGENATION; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PATHOGENESIS; PATHOPHYSIOLOGY; REVIEW; VIRUS MYOCARDITIS; BIOPSY; CARDIOMYOPATHIES; CHILD; COMPLICATION; DISEASE MANAGEMENT; MYOCARDITIS; PROCEDURES; PROGNOSIS; VIROLOGY;

ACUTE DISEASE; BIOPSY; CARDIOMYOPATHIES; CHILD; DISEASE MANAGEMENT; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MYOCARDITIS; PROGNOSIS;

EID: 84949730246     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/14779072.2016.1114884     Document Type: Review

References (49)

1. Ghelani SJ, Spaeder MC, Pastor W, et al. Demographics, trends, and outcomes in pediatric acute myocarditis in the United States, 2006 to 2011. Circ Cardiovasc Qual Outcomes. 2012;5:622-627.
2. Towbin JA1, Lowe AM, Colan SD, et al. Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA. 2006;296:1867-1876.
3. Klugman D, Berger JT, Sable CA, et al. Pediatric patients hospitalized with myocarditis: a multi-institutional analysis. Pediatr Cardiol. 2010;31:222-228.
4. Weber MA, Ashworth MT, Risdon RA, et al. Clinicopathological features of paediatric deaths due to myocarditis: an autopsy series. Arch Dis Child. 2008;93:594-598.
5. Vetter VL, Covington TM, Dugan NP, et al. Cardiovascular deaths in children: general overview from the National Center for the Review and Prevention of Child Deaths. Am Heart J. 2015;169:426-437.
6. Simpson K, Storch GA, Lee CK, et al. Blood viral PCR frequently identifies cardiotropic viruses in pediatric patients with clinical myocarditis or recent onset dilated cardiomyopathy at time of presentation [abstract]. J Am Coll Cardiol. 2013;61: A312.
7. Bowles NE, Ni J, Kearney DL, et al. detection of viruses in myocardial tissues by polymerase chain reaction: evidence of adenovirus as a common cause of myocarditis in children and adults. J Am Coll Cardiol. 2003;42:466-472.
8. Yajima T, Knowlton KU. Viral myocarditis: from the perspective of the virus. Circulation. 2009;119:2615-2624.
9. Liu PP, Mason JW. Advances in the understanding of myocarditis. Circulation. 2001;104:1076-1082.
10. Kindermann I, Barth C, Mahfoud F, et al. Update on myocarditis. J Am Coll Cardiol. 2012;59:779-792.
11. Canter CE, Simpson KP. Diagnosis and treatment of myocarditis in children in the current era. Circulation. 2014;129:115-128.
12. Richardson P, McKenna W, Bristow M, et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation. 1996;93:841-842.
13. Blauwet LA, Cooper LT. Myocarditis. Prog Cardiovasc Dis. 2010;52:274-288.
14. Matsumuto Y, Park IK, Kohyama K. Matrix metalloproteinase (MMP)-9, but not MMP-2, is involved in the development and progression of C proteininduced myocarditis and subsequent dilated cardiomyopathy. J Immunol. 2009;183:4773-4781.
15. Westerman D, Savvatis K, Schultheiss HP, et al. Immunomodulation and matrix metalloproteinases in viral myocarditis. J Mol Cell Cardiol. 2010;48:468-473.
16. Aretz HT, Billingham ME, Edwards WD, et al. Myocarditis: a histopathologic definition and classification. Am J Cardiovasc Pathol. 1987;1:3-14.
17. Baughman KL. Diagnosis of myocarditis: death of Dallas criteria. Circulation. 2006;113:593-595.
18. Das BB. Role of Endomyocardial biopsy for children presenting with acute systolic heart failure. Pediatr Cardiol. 2014;35:191-196.
19. Shauer A, Gotsman I, Keren A, et al. Acute viral myocarditis: current concepts in diagnosis and treatment. Imaj. 2013;15:180-185.
20. Schultz JC, Hilliard AA, Cooper LT Jr, et al. Diagnosis and treatment of viral myocarditis. Mayo Clin Proc. 2009;84:1001-1009.
21. Cooper LT1, Baughman KL, Feldman AM, et al. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology. Eur Heart J. 2007;28:3076-3093.
22. Friedrich MG, Sechtem U, Schulz-Menger J. for the international consensus group on cardiovascular magnetic resonance in myocarditis. Cardiovascular magnetic resonance in myocarditis: a JACC white paper. J Am Coll Cardiol. 2009;53:1475-1487.
23. Lurz P, Eitel I, Adam J, et al. Diagnostic performance of CMR Imaging compared with EMB in patients with suspected myocarditis. J Am Coll Cardiol Img. 2012;5:513-524.
24. Sachdeva S, Song X, Dham N, et al. Analysis of clinical parameters and cardiac magnetic resonance imaging as predictors of outcome in pediatric myocarditis. Am J Cardiol. 2015;115:499-504.
25. Robinson J, Hartling L, Vandermeer B, et al. Intravenous immunoglobulin for presumed viral myocarditis in children and adults. Cochrane Database Syst Rev. 2005;1:CD004370.
26. Kishimoto C, Shioji K, Hashimoto T, et al. Therapy with immunoglobulin in patients with acute myocarditis and cardiomyopathy: analysis of leukocyte balance. Heart Vessels. 2014;29:336-342.
27. McNamara DM, Holubkov R, Starling RC, et al. Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. Circulation. 2001;103:2254-2259.
28. Drucker NA, Colan SD, Lewis AB, et al. Gamma-globulin treatment of acute myocarditis in the pediatric population. Circulation. 1994;89:252-257.
29. Klugman D, Berger JT, Sable CA, et al. Pediatric patients hospitalized with myocarditis: a multi-institutional analysis. Pediatr Cardiol Feb. 2010;31:222-228.
30. Chen HS, Wang W, Wu SN, et al. Corticosteroids for viral myocarditis. Cochrane Database Syst Rev. 2013 Oct 18; 10: CD004471.
31. Mason JW, O'Connell JB, Herskowitz A, et al. Myocarditis Treatment Trial Investigators. A clinical trial of immunosuppressive therapy for myocarditis. N Engl J Med. 1995;333:269-275.
32. Stanton C, Mookadam F, Cha S, et al. Greater symptom duration predicts response to immunomodulatory therapy in dilated cardiomyopathy. Int J Cardiol. 2008;128:38-41.
33. Frustaci A, Russo MA, Chimenti C. Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study. Eur Heart J. 2009;30:1995-2002.
34. Wojnicz R, Nowalany-Kozielska E, Wojciechowska C, et al. Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year followup results. Circulation. 2001;104:39-45.
35. Kühl U, Pauschinger M, Noutsias M, et al. High prevalence of viral genomes and multiple viral infections in the myocardium of adults with "idiopathic" left ventricular dysfunction. Circulation. 2005;111:887-893.
36. Kühl U, Pauschinger M, Seeberg B, et al. Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation. 2005;112:1965-1970.
37. Kuethe F, Sigusch HH, Hilbig K, et al. Detection of viral genome in the myocardium: lack of prognostic and functional relevance in patients with acute dilated cardiomyopathy. Am Heart J. 2007;153:850-858.
38. Levi D, Alejos J. Diagnosis and treatment of pediatric viral myocarditis. Curr Opin Cardiol. 2001;16:77-83.
39. Miric M, Vasiljevic J, Bojic PZ, et al. Long-term follow up of patients with dilated heart muscle disease treated with human leucocytic interferon alpha or thymic hormones initial results. Heart. 1996;75:596-601.
40. Kuhl U, Pauschinger M, Schwimmbeck PL, et al. Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. Circulation. 2003;107:2793-2798.
41. Teele SA, Allan CK, Laussen PC, et al. Management and outcomes in pediatric patients presenting with acute fulminant myocarditis. J Pediatr. 2011;158:638-643.
42. Rajagopal SK1, Almond CS, Laussen PC, et al. Extracorporeal membrane oxygenation for the support of infants, children, and young adults with acute myocarditis: a review of the extracorporeal life support organization registry. Crit Care Med. 2010;38:382-387.
43. Maybaum S1, Mancini D, Xydas S, et al. LVAD working group. Cardiac improvement during mechanical circulatory support: a prospective multicenter study of the LVAD working group. Circulation. 2007;115:2497-2505.
44. Pietra BA, Kantor PF, Bartlett HL, et al. Early predictors of survival to and after heart transplantation in children with dilated cardiomyopathy. Circulation. 2012;126:1079-1086.
45. Kaye DM, Lefkovits J, Jennings GL, et al. Adverse consequences of high sympathetic nervous activity in the failing human heart. J Am Coll Cardiol. 1995;26:1257-1263.
46. Merit HF. Study group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet. 1999;353:2001-2007.
47. Kindermann I, Kindermann M, Kandolf R, et al. Predictors of outcome in patients with suspected myocarditis. Circulation. 2008;118:639-648.
48. Neves MF, Amiri F, Virdis A, et al. CIHR multidisciplinary research group on hypertension. Role of aldosterone in angiotensin Ii-induced cardiac and aortic inflammation, fibrosis, and hypertrophy. Can J Physiol Pharmacol. 2005;83:999-1006.
49. Kuster GM, Kotlyar E, Rude MK, et al. Mineralocorticoid receptor inhibition ameliorates the transition to myocardial failure and decreases oxidative stress and inflammation in mice with chronic pressure overload. Circulation. 2005;111:420-427.